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ABSTRACT
Objectives: To examine links between clinical and
other characteristics of people with Alzheimer’s disease
living in the community, likelihood of care home or
hospital admission, and associated costs.
Design: Observational data extracted from clinical
records using natural language processing and
Hospital Episode Statistics. Statistical analyses
examined effects of cognition, physical health, mental
health, sociodemographic factors and living
circumstances on risk of admission to care home or
hospital over 6 months and associated costs, adjusting
for repeated observations.
Setting: Catchment area for South London and
Maudsley National Health Service Foundation Trust,
provider for 1.2 million people in Southeast London.
Participants: Every individual with diagnosis of
Alzheimer’s disease seen and treated by mental health
services in the catchment area, with at least one rating
of cognition, not resident in care home at time of
assessment (n=3075).
Interventions: Usual treatment.
Main outcome measures: Risk of admission to,
and days spent in three settings during 6-month period
following routine clinical assessment: care home,
mental health inpatient care and general hospital
inpatient care.
Results: Predictors of probability of care home or
hospital admission and/or associated costs over
6 months include cognition, functional problems,
agitation, depression, physical illness, previous
hospitalisations, age, gender, ethnicity, living alone and
having a partner. Patterns of association differed
considerably by destination.
Conclusions: Most people with dementia prefer to
remain in their own homes, and funding bodies see
this as cheaper than institutionalisation. Better
treatment in the community that reduces health and
social care needs of Alzheimer’s patients would reduce
admission rates. Living alone, poor living
circumstances and functional problems all raise
admission rates, and so major cuts in social care
budgets increase the risk of high-cost admissions
which older people do not want. Routinely collected
data can be used to reveal local patterns of admission
and costs.
INTRODUCTION
Central to any dementia plan or policy
framework is the question of how to achieve
the best health and quality of life outcomes
for people with dementia and their carers,
while ensuring that systems of treatment and
support make the best use of available
resources and are affordable. An important
consideration is the balance between care in
community and institutional settings. Most
people with dementia want to remain living
Strengths and limitations of this study
▪ We analysed detailed, electronic clinical records
of more than 3000 individuals with Alzheimer’s
disease using natural language processing to
generate some of the data.
▪ We looked at three institutional destinations sep-
arately: care home, general hospital inpatient and
mental health inpatient.
▪ Our analyses controlled for a wide range of
patient characteristics as potential confounders,
but we were constrained by what was available
in the records-derived data set.
▪ Measures used in routine clinical care may lack
precision, which cautions against overinterpreta-
tion of findings.
▪ We did not have comprehensive data on usage
of primary or community health or social care
services.
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in their own homes for as long as possible, and delaying
care home admission is rated as highly important by
carers.1 Supporting people in the community is also very
often a less costly option to the public purse than either
residence in a care home or (especially) an inpatient
admission.2 The need to get the optimal community–
institutional balance is especially important given projec-
tions of rapidly increasing numbers of people with
dementia over the coming decades.3
Of course, inpatient admissions are appropriate in
order to meet speciﬁc health needs, and care homes
can provide high-quality care for people with severe
symptoms, but admissions to these settings sometimes
stem from potentially avoidable crises in the commu-
nity.4–6 Not surprisingly, admission to care home or hos-
pital has, therefore, also been taken as a pivotal event in
technology appraisal models, such as that undertaken
for the National Institute for Health and Care
Excellence to inform guidance on dementia treatment.7
We examine the links between the clinical and other
characteristics of people with Alzheimer’s disease living
in the community—particularly their cognitive function
and other needs associated with dementia—and both
the likelihood of admission to a care home or hospital
within a 6-month period, and the associated costs of
those admissions. We employ medical records data for
more than 3000 people, representing all Alzheimer’s
disease patients seen and treated by mental health ser-
vices in a large catchment area of Southeast London. We
use natural language processing to extract some of the
data from records, an approach not previously employed
with ‘real-world’ data in this kind of study.
METHODS
Design and participants
Data were extracted from routine care data derived from
electronic medical records of the South London and
Maudsley National Health Service (NHS) Foundation
Trust (SLAM). SLAM provides comprehensive secondary
mental healthcare to a catchment area of ∼1.2 million
residents in four London boroughs (Lambeth,
Southwark, Lewisham and Croydon), making it one of
the largest mental health providers in Europe. SLAM
service provision encompasses all aspects of secondary
mental healthcare across all age groups, including
inpatient, community, general hospital liaison and foren-
sic services. Fully electronic health records have been
used comprehensively across all SLAM services since
2006, importing earlier legacy data, and the Clinical
Record Interactive Search (CRIS) system, supported by
SLAM’s NIHR Biomedical Research Centre for Mental
Health, was developed in 2008 to enable researchers to
search and retrieve past and current anonymised clinical
records within a secured ﬁrewall efﬁciently. There are
currently over 250 000 cases represented in the CRIS
system providing in-depth information on mental health-
care provision, including dementia assessment and
treatment. The protocol for CRIS is described else-
where,8 9 as are its anonymisation and data governance
structures. CRIS was approved as a data set for secondary
analysis on this basis by Oxfordshire Research Ethics
Committee C (08/H0606/71+5).
The sample for analysis comprised every individual in
the CRIS system with a diagnosis of Alzheimer’s disease
(from structured ICS10 and GATE data) and at least
one Mini-Mental State Examination (MMSE) rating, and
who was not resident in a care home at the time of
MMSE assessment. We also excluded individuals whose
ﬁrst contact was with a liaison team. The MMSE10 is
widely used as a measure of cognitive function in clinical
services providing specialist dementia care, and was
chosen as the measure of exposure for this analysis.
From the date of the ﬁrst MMSE recorded at the time of
dementia diagnosis or up to 90 days beforehand, a
6-month follow-up period (‘observation window’) was
deﬁned and investigated for care home and hospitalisa-
tion outcomes. Another 6-month window was started
from the next MMSE score after this follow-up period,
but MMSE scores falling within a given window were
ignored. Thus, patients with multiple MMSE scores
could contribute several non-overlapping follow-up
periods (windows) to the analysis so long as the assess-
ments were more than 6 months apart, and our statis-
tical analyses were planned to explore the impact of
repeat observations. It would have been possible to look
at longer observation windows, but we decided (pre-
analysis) to use 6-month windows as a balance between
the need for long enough periods to identify impacts on
admission and the potential to have multiple windows
linked to different baseline levels of cognitive function
and other potential inﬂuences.
Data were extracted in November 2012 and any
follow-up period overlapping the analysis date was
dropped from the analysis.
Measurements
Destination outcome measures were drawn from the
mental health record (CRIS) and a data linkage made
to UK Hospital Episode Statistics (HES) for all indivi-
duals on CRIS. For each relevant MMSE assessment
point (ie, starting a 6-month window), we used data
from CRIS and HES to measure the number of days
spent in each of three settings during the subsequent
6 months: care home, mental health inpatient care and
general hospital inpatient care. We also summed these
measures to give the number of days in any institutional
setting during the 6-month window. These four destin-
ation outcome measures were used as dependent vari-
ables in multivariate analyses.
Care home admissions were ascertained from the
mental health record using two techniques. The ﬁrst was
an algorithm linking the address ﬁelds in the source
record to known addresses of care homes for older
people in the catchment area (address ﬁelds themselves
remaining blinded to researchers as part of the
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anonymisation pipeline in CRIS). This was supplemen-
ted with a manual search of free-text ﬁelds in CRIS over
relevant time periods. We excluded care home admis-
sions for respite care (as recorded in CRIS). Once an
individual had been admitted to a care home, no
further data were collected on care home status,
although hospital inpatient admissions data continue to
be collected (ie, care home admissions not speciﬁed as
being for respite care were assumed to be permanent).
Inpatient admissions to mental healthcare facilities (all
of which are provided for the catchment by SLAM) were
obtained from CRIS, while inpatient admissions to
general/acute hospitals were obtained from HES. The
number of care home days until death (or the end of a
6-month period, whichever occurred ﬁrst) was used to
generate one of the outcome measures. A care home
resident subsequently receiving inpatient care will have
their care home place kept open for them, and so paral-
lel costs were assumed in these circumstances.
The presence of Alzheimer’s disease diagnosis was
ascertained from a combination of structured ﬁelds of
psychiatric diagnosis and data obtained using a natural
language processing information extraction application
which extracts text associated with diagnostic statements
in case notes and correspondence letters, taking into
account the linguistic context of relevant terms. We used
Generalised Architecture for Text Engineering (GATE;
https://gate.ac.uk/), an open-source platform for
natural language processing to extract relevant data
from the non-coded, or narrative data, recorded by
healthcare workers and which forms a considerable part
of the medical record.11 The performance of this auto-
mated approach against manual coding for a subsample
(n=123) of patients indicates precision (positive predict-
ive value) of 93% and recall (sensitivity) >99%.12
NHS numbers (unique identiﬁers for UK NHS
medical records) for all previous and current SLAM con-
tacts are checked monthly against the national mortality
database,13 and date of death was thus ascertained from
the clinical record and made available for analysis.
Regressors for the analyses were all extracted from
coded data held in the electronic medical records
(EMRs) using CRIS, each relating to the patient’s situ-
ation at the start of the 6-month period. These com-
prised the following sociodemographic measures: age
(in years); gender; ethnicity (collated into the following
groups: (i) Caribbean, African or other Black; (ii) East
Asian or South Asian; (iii) mixed, unknown, or other;
(iv) White British or Other White; the last of these was
the reference group in the regressions); marital status
(married, cohabiting, civil partnership, compared to
those with no partner); and living alone (binary vari-
able: yes/no).
Cognition was measured from clinically recorded
30-item MMSE scores, ascertained from structured ﬁelds
in the clinical record and supplemented by scores
recorded in case note and/or correspondence text
ﬁelds ascertained by a natural language processing
application.14 15 Where MMSE assessments were substan-
tially incomplete (denominator scores below 20), these
were not included in the analysis; otherwise missing
items were coded as successfully completed. We analysed
the MMSE score as a continuous measure and also its
squared term to test for non-linearity in the association
with admission and cost.
The Health of the Nation Outcome Scales (HoNOS)
are routinely completed and included in the coded data
as a mandatory item in the EMR for all SLAM service
users as a component of the national mental health
minimum data set. We extract HoNOS subscale scores
for: living conditions, activities of daily living (ADL),
physical illness/disability, agitated behaviour, depression
and relationship problems. Each item is scored on a
5-point scale: not a problem (score 0), minor problem
requiring no action (score 1), mild problem but deﬁn-
itely present (score 2), moderately severe problem (score
3) and severe to very severe problem (score 4).16–19 We
recoded each subscale so as to create two dummy vari-
ables for each dimension: one dummy variable for minor
problems (original HoNOS score of 1 given the value 1; all
other original HoNOS scores given the value 0) and the
second dummy variable for signiﬁcant problems (original
HoNOS scores of 2, 3 or 4 given the value 1; all other ori-
ginal HoNOS scores given the value 0).
We also included two binary variables representing
admission or not to mental health inpatient care (coded
0 and 1 respectively), and admission or not to general
hospital inpatient care (coded 0 and 1 respectively),
during the 12 months preceding the start of the
6-month ‘analysis window’. Finally, we included a vari-
able indicating the year in which the data were collected
(four binary dummy variables for time periods 2007,
2008, 2009, and 2010 or later; each coded 1 for yes, 0
for no).
Each sociodemographic, accommodation, MMSE,
HoNOS and previous admission variable referred to the
patient’s situation at the start of the 6-month window,
whereas the dependent variables were indicators of
admission and costs of all days in each setting over the
subsequent 6 months.
Unit costs
Unit costs were taken from the PSSRU Health and Social
Care Costs volume (2010/11 prices)20 and represent
national averages. Private sector nursing home costs
were £103 per person per day, and almost all care home
admissions for this sample would have been to private
sector facilities offering nursing care. Mental healthcare
(older adult) inpatient stays cost £319 per person per
day. As there was no ﬁgure in the 2011 PSSRU volume
for geriatric hospital stay, we uprated the 2008 ﬁgure to
2010/2011 prices: £274 per person per day. These unit
costs include all accommodation-related and care costs
included within facility budgets. It is not possible to
attach unit costs that reﬂect different levels of need
within a care home or hospital setting.
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In England, hospital inpatient costs fall to the NHS.
Costs of care home stays could be covered by the NHS,
local authority and (private) self-funders, although we
did not know these cost allocations for individuals in our
sample. We did not have data on usage of primary or
community health or social care services.
Statistical analysis
In summary, our approach was to employ logistic regres-
sion to model admission probabilities in the entire
sample, and then employ generalised linear models
(GLM) to describe the associated costs for the sub-
sample who had these admissions. Relationships
between admission probabilities, costs and cognitive
impairment were non-linear, so we calculated estimates
of the effects for three ‘case types’ representing mild,
moderate and severe cognitive impairment. We now
explain why we adopted this approach.
Our analysis strategy anticipated that a high propor-
tion of individuals would have no stays in a care home
or inpatient setting during the 6-month window, render-
ing the cost variables highly right-skewed, and potentially
making least squares estimation biased and inefﬁcient.21
We therefore employed two-part models (TPM) in the
estimation process:22 the ﬁrst part estimated the prob-
ability of institutionalisation during the 6-month window
for the entire sample and the second part estimated
costs only for those patients who spent time in the insti-
tutional setting (ie, with non-zero costs). This TPM strat-
egy allowed inferences about care home or inpatient
costs to be augmented with information about probabi-
lity of service use.23 Adjusted estimates of average costs
were obtained by multiplying the estimated average
probability of service use (from the ﬁrst part) by average
costs (from the second part). We used logistic regression
models (XTGEE) to estimate probabilities for each des-
tination outcome, and generalised estimating equations
(GEE) with log-link and gamma family distribution to
estimate costs for those patients incurring non-zero
costs, conditional upon use. In both parts, we adjusted
for repeated observations, because sample members
could have more than one observation ‘window’. The
exception was the second part for care home admissions
because these could not be repeated for the same
individual.
For each model, the appropriateness of error distribu-
tion assumptions was examined using Park’s test24 in
line with recommendations in Manning and Mullahy.25
We used gamma, which is a ﬂexible distribution often
used for modelling healthcare costs.
To illustrate the impact of cognitive impairment on
probability and cost of institutionalisation—given the
non-linear relationship between MMSE and expected
service use—we selected three MMSE values (‘case
values’) to represent mild dementia (MMSE score of
24), moderate dementia (MMSE of 16) and severe
dementia (MMSE of 6), examining other ‘case values’ in
sensitivity analyses (see below). These estimates reﬂect
average marginal effects (AME) at representative
values26 (keeping other characteristics as observed)27
and we also compared costs between these different
severity levels. We are not seeking to model disease
progression.
The estimates of marginal effects were obtained using
the margins command in Stata V.11. Estimates were
bootstrapped 10 000 times to obtain CIs. We also boot-
strapped the cost difference between case types to help
interpret the impact of MMSE on costs.
Sensitivity analysis
We re-estimated the TPMs using GLM rather than GEE
(ie, ignoring the fact that there were repeated
observations).
Cognitive impairment can lead to other problems,
such as with ADLs and depression, and the inclusion of
these latter variables in the regression could lead to
underestimation of the ‘total’ underlying effect of cogni-
tion on probability of admission and costs. We
re-estimated all speciﬁcations after omitting the ADL
and depression variables to see the effect on the MMSE
variable coefﬁcients.
To test whether our ﬁndings were sensitive to the
MMSE values chosen for severe, moderate and mild cog-
nitive impairment (scores of 6, 16 and 24), we repeated
our bootstrapping analyses with a different set of MMSE
‘case values’ (scores of 9, 16 and 22).
We also calculated marginal effects at means (MEMs)
as an alternative toAME,27 again using the margins
command in Stata V.11, bootstrapping 10 000 times to
obtain CIs.
RESULTS
Sample
Data were available for 3075 patients: two-thirds were
women; 82% were of white ethnicity; 8% aged under
70 years and 9% aged over 89 years (at the beginning of
the ﬁrst observation period for each; table 1). Just over
one-third had a partner, and one-quarter of them were
living alone. Of MMSE scores at the start of the ﬁrst
6-month windows, 11% were 0–10 (severe dementia)
and 45% were 11–20 (moderate dementia).
Approximately half of the sample (52.2%) had signiﬁ-
cant problems with ADL, and around a third (36.7%)
had signiﬁcant problems with physical illness. Smaller
proportions were rated as having signiﬁcant problems
with agitation (15.1%), relationships (14.8%), depres-
sion (10.8%) or living conditions (9.5%).
During the 6-month study ‘windows’ examined, 195
patients received at least one mental health inpatient
admission, 1140 had a general hospital admission and
361 had a care home admission. Between them, the
3075 individuals in the sample had 5912 eligible
6-month ‘windows’ during the study period. There were
missing data on one or more variables for 266 (4.5%) of
these ‘windows’, which were dropped from the analysis.
4 Knapp M, et al. BMJ Open 2016;6:e013591. doi:10.1136/bmjopen-2016-013591
Open Access
group.bmj.com on December 9, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
In the total of 5624 included ‘windows’, there were 1474
individuals with 1 ‘window’, 637 with 2 windows, 318
with 3, 183 with 4, 92 with 5, 58 with 6, 22 with 7, 14
with 8, 3 with 9, 4 with 10, 2 with 12 and 2 with 14.
Admission probability and costs
The results of the TPM are shown in tables 2–5. The left-
hand side of each table shows the association between
the probability of admission and cognitive impairment and
other explanatory factors. The right-hand side of each
table shows the association between costs of those admis-
sions and cognitive impairment and other factors. As
the models are estimated using a log-link function,
model estimates are reported in exponentiated form to
aid interpretation. This re-expresses the associations in
the ﬁrst part as ORs. For the second part, the associa-
tions are re-expressed as ratios of expected cost, which
can be interpreted as the percentage change in esti-
mated costs (=100×[exp(b)−1]) for each unit change in
an independent variable.
Model limitations were explored by examining
residual plots, which showed no apparent patterns of
prediction errors in all but one model. The exception
was the model for costs of mental health-related
inpatient admissions, for which there appeared to be
underprediction at lower levels of cost and overpredic-
tion at higher levels, potentially a consequence of the
small number of patients with such an admission.
Year
Year of assessment was generally not linked to probabil-
ity or cost, but there were exceptions: probability of
general hospital inpatient admission was signiﬁcantly
higher in 2008 than in other years, and probability of
mental health inpatient admission was signiﬁcantly lower
in 2009, 2010 or later compared to earlier years (with
2006 as the reference year throughout).
Previous admissions
Prior experience of general hospital inpatient care and
mental health inpatient care were strongly predictive of
the probability of admission in the study window, to care
homes and mental health inpatient treatment; and pre-
vious general hospital inpatient care strongly predicted
later general hospital admission. Previous admissions
were also associated with general hospital inpatient
costs, and previous mental health inpatient care was
associated with mental health inpatient costs.
Age and other demographic characteristics
After adjustment, older patients had higher probability
of admission to all three settings, and older age was also
a predictor of higher general hospital inpatient costs.
Males had higher rates of admission to general hospital
settings than males, as well as of any institutional
admission. Relative to white ethnicity and after adjust-
ment, Caribbean/African ethnicity was associated with
a lower probability of care home admission and
general hospital inpatient admission, and shorter
lengths of stay (shown as costs) in general hospital set-
tings (and overall in institutional settings). Mixed/
unknown ethnicity was associated with lower probabil-
ity of care home admission. East/South Asian ethnicity
Table 1 Sample characteristics at the beginning of the
first 6-month observation period (3075 individuals)
Variables (and missing values
for the first observation
window)
N individuals
(% of non-missing
observations)
MMSE score (missing data for 0 individuals)
0–10 323 (10.5)
11–20 1391 (45.2)
21–30 1361 (44.3)
Age (missing data for 0)
40–59 years 43 (1.4)
60–69 years 207 (6.7)
70–79 years 1049 (34.1)
80–89 years 1486 (48.3)
90 years or above 289 (9.4)
Gender (missing data for 3)
Female 2059 (67.0)
Male 1013 (33.0)
Ethnicity (missing data for 0)
White 2529 (82.2)
Caribbean/African 310 (10.1)
East/South Asian 96 (3.1)
Mixed/unknown 140 (4.6)
Partner (missing data for 0)
No 1956 (63.6)
Yes 1119 (36.4)
Living alone (missing data for 0)
No 2277 (74.1)
Yes 798 (26.0)
Living conditions (HoNOS11) (missing data for 214)
Not a problem 2171 (75.6)
Minor problems only 426 (14.8)
Significant problems 274 (9.5)
ADL (HoNOS10) (missing data for 186)
Not a problem 651 (22.5)
Minor problems only 729 (25.2)
Significant problems 1509 (52.2)
Physical illness (HoNOS5) (missing data for 186)
Not a problem 965 (33.4)
Minor problems only 865 (29.9)
Significant problems 1059 (36.7)
Agitated (HoNOS1) (missing data for 181)
Not a problem 1918 (66.3)
Minor problems only 538 (18.6)
Significant problems 436 (15.1)
Depression (HoNOS7) (missing data for 185)
Not a problem 1818 (62.9)
Minor problems only 760 (26.3)
Significant problems 312 (10.8)
Relationship problems (HoNOS9) (missing data for 188)
Not a problem 1877 (65.0)
Minor problems only 582 (20.2)
Significant problems 428 (14.8)
HoNOS, Health of the Nation Outcome Scale; MMSE, Mini-Mental
State Examination.
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was also associated with a lower probability of general
hospital inpatient admission.
Living situation
Individuals with a partner had a lower probability of
admission to care homes and general hospital
inpatient settings, but higher probability of mental
health inpatient admission, and those living alone had
a higher probability of admission to all settings.
Considering all three institutional settings, costs were
higher for patients without a partner or living alone,
conditional on admission.
Symptoms and needs
Considering HoNOS variables, problems with living con-
ditions were associated with higher probability of admis-
sion to each type setting, but did not affect costs except
when all settings are grouped together, when costs
were signiﬁcantly higher. ADL problems were associated
with care home admission and overall risk of
Table 2 Two-part model estimates for care home admission
Probability of admission in 6 months Cost of admission over 6 months
N=5624 N=361
95% CI 95% CI
Regressors OR
Lower
bound
Upper
bound p Value
Exp
(b)
Lower
bound
Upper
bound p Value
MMSE 1.08 1.00 1.16 0.06 1.00 0.95 1.04 0.90
MMSE (squared) 1.00 0.99 1.00 <0.01 1.00 1.00 1.00 0.96
Year (Ref: 2006 or earlier)
2007 1.00 0.69 1.46 0.99 0.91 0.75 1.10 0.32
2008 1.27 0.89 1.81 0.18 0.84 0.71 1.01 0.06
2009 1.08 0.75 1.55 0.67 0.97 0.81 1.17 0.78
2010 or later 1.00 0.71 1.41 0.99 1.00 0.85 1.18 0.98
Prior 12m General hospital
inpatient care (Ref: No history)
1.54 1.22 1.94 <0.01 0.97 0.86 1.10 0.66
Prior 12m Mental health inpatient
care (Ref: No history)
2.59 1.42 4.74 <0.01 1.18 0.94 1.49 0.15
Age 1.04 1.02 1.06 <0.01 1.00 0.99 1.01 0.88
Gender (0=female; 1=male) 1.11 0.85 1.44 0.44 0.99 0.86 1.14 0.90
Ethnicity (Ref: White)
Caribbean/African 0.57 0.38 0.86 0.01 1.11 0.93 1.33 0.23
East/South Asian 0.57 0.24 1.34 0.20 1.12 0.77 1.64 0.56
Mixed/unknown 0.30 0.12 0.74 0.01 0.83 0.54 1.30 0.42
Partner (Ref: No partner) 0.60 0.45 0.80 <0.01 0.91 0.78 1.05 0.19
Living alone (Ref: Not) 1.29 0.99 1.67 0.06 0.84 0.74 0.97 0.01
Living conditions (HoNOS11)
Minor problems only 1.59 1.19 2.12 <0.01 0.99 0.87 1.14 0.93
Significant problems 1.65 1.18 2.32 <0.01 1.07 0.91 1.27 0.41
ADL (HoNOS10)
Minor problems only 1.17 0.72 1.91 0.53 0.90 0.68 1.20 0.49
Significant problems 1.87 1.21 2.90 0.01 0.92 0.71 1.20 0.53
Physical illness (HoNOS5)
Minor problemsonly 1.10 0.80 1.51 0.58 1.06 0.90 1.25 0.50
Significant problems 1.23 0.91 1.68 0.18 0.98 0.84 1.16 0.84
Agitated (HoNOS1)
Minor problems only 1.41 1.05 1.89 0.02 1.02 0.88 1.19 0.76
Significant problems 1.98 1.45 2.70 <0.01 1.03 0.89 1.19 0.68
Depression (HoNOS7)
Minor problemsonly 0.94 0.72 1.24 0.68 1.10 0.96 1.25 0.16
Significant problems 1.13 0.79 1.60 0.51 1.02 0.86 1.20 0.82
Relationship (HoNOS9)
Minor problems only 1.10 0.82 1.48 0.51 0.98 0.85 1.13 0.78
Significant problems 1.22 0.88 1.69 0.24 0.97 0.82 1.13 0.67
Constant term <0.01 <0.01 0.01 <0.01 11 356 4272 30 188 <0.01
Reference group for all HoNOS variables: no problem. Exp(b) estimate is the ratio of expected cost, which can be interpreted as the
percentage change in estimated costs (=100×[exp(b)−1]) for each unit change in an independent variable.
HoNOS, Health of the Nation Outcome Scale; MMSE, Mini-Mental State Examination.
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institutionalisation, but not with costs, or with the prob-
ability or cost of either type of hospital admission. The
physical illness score was not associated with care home
admission or cost, but was associated with a higher prob-
ability of general hospital and mental health inpatient
admissions and overall institutionalisation, as well as with
higher general inpatient costs. Agitation was associated
with higher admission probability into each type of
setting, and (overall) with costs. Depression was asso-
ciated with higher probability of general hospital and
mental health inpatient admissions, but not care home
admission, and with higher mental health inpatient and
overall costs. Relationship problems were not associated
with either admission or costs, apart from a higher prob-
ability of mental health inpatient admission.
Cognitive impairment
Cognitive impairment (measured by MMSE and its
square term) was a signiﬁcant predictor of care home
admission and general hospital inpatient admission, but
Table 3 Two-part model estimates for general hospital inpatient admission
Probability of admission in 6 months Cost of admission over 6 months
N=5624 N=1140
95% CI 95% CI
Regressors OR
Lower
bound
Upper
bound p Value
Exp
(b)
Lower
bound
Upper
bound p Value
MMSE 0.93 0.88 0.97 <0.01 0.99 0.95 1.03 0.64
MMSE (squared) 1.00 1.00 1.00 0.06 1.00 1.00 1.00 0.98
Year (Ref: 2006 or earlier)
2007 1.05 0.83 1.33 0.67 1.13 0.90 1.40 0.29
2008 1.33 1.07 1.67 0.01 0.97 0.79 1.20 0.81
2009 1.23 0.98 1.54 0.07 0.93 0.75 1.16 0.53
2010 or later 1.16 0.93 1.43 0.19 1.07 0.87 1.30 0.53
Prior 12m General hospital
inpatient care (Ref: No history)
2.21 1.92 2.55 <0.01 1.14 1.00 1.29 0.05
Prior 12m Mental health inpatient
care (Ref: No history)
0.83 0.48 1.42 0.49 1.71 1.13 2.58 0.01
Age 1.04 1.02 1.05 <0.01 1.02 1.01 1.03 <0.01
Gender (0=female; 1=male) 1.36 1.16 1.61 <0.01 0.93 0.81 1.08 0.34
Ethnicity (Ref: White)
Caribbean/African 0.68 0.53 0.88 <0.01 0.68 0.53 0.88 <0.01
East/South Asian 0.43 0.25 0.73 <0.01 0.77 0.52 1.15 0.21
Mixed/unknown 1.35 0.93 1.96 0.11 0.98 0.74 1.31 0.90
Partner (Ref: No partner) 0.77 0.67 0.93 <0.01 0.87 0.74 1.02 0.09
Living alone (Ref: Not) 1.26 1.05 1.49 0.01 1.11 0.95 1.30 0.18
Living conditions (HoNOS11)
Minor problems only 1.47 1.22 1.79 <0.01 1.13 0.96 1.33 0.16
Significant problems 1.75 1.37 2.22 <0.01 1.12 0.94 1.34 0.22
ADL (HoNOS10)
Minor problems only 1.15 0.91 1.45 0.25 1.15 0.90 1.46 0.25
Significant problems 1.25 1.00 1.57 0.05 1.18 0.94 1.47 0.15
Physical illness (HoNOS5)
Minor problems only 1.30 1.07 1.57 <0.01 1.09 0.89 1.34 0.42
Significant problems 2.15 1.78 2.60 <0.01 1.33 1.14 1.63 <0.01
Agitated (HoNOS1)
Minor problems only 1.11 0.92 1.35 0.27 1.17 1.00 1.38 0.06
Significant problems 1.50 1.21 1.88 <0.01 1.12 0.95 1.33 0.19
Depression (HoNOS7)
Minor problems only 0.96 0.81 1.14 0.63 0.94 0.81 1.09 0.41
Significant problems 1.49 1.18 1.88 <0.01 1.02 0.84 1.24 0.85
Relationship (HoNOS9)
Minor problems only 1.01 0.84 1.22 0.91 1.02 0.87 1.19 0.80
Significant problems 0.98 0.78 1.24 0.88 1.06 0.88 1.29 0.54
Constant term 0.01 0.00 0.03 <0.01 980.20 386.06 2488.75 <0.01
Reference group for all HoNOS variables: No problem. Exp(b) estimate is a ratio of expected cost, which can be interpreted as the percentage
change in estimated costs (=100×[exp(b)−1]) for each unit change in an independent variable.
HoNOS, Health of the Nation Outcome Scale; MMSE, Mini-Mental State Examination.
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not a predictor of mental health inpatient admission.
However, MMSE did not predict the cost of admission for
those admitted to any of the destinations. When looking
at all forms of institutional admission together (table 5),
worse cognitive impairment was signiﬁcantly associated
with a higher probability of admission.
Table 6 presents marginal mean probability of service
use alongside the marginal mean costs in the 6-month
window, using the AME procedure. For instance, the
probability of being admitted to a care home within a
6-month window was 10% on average for those with
severe cognitive impairment. In this group, those who
were admitted to a care home generated costs averaging
£10 172 over 6 months. Combining the two parts of the
model, we found that people with severe cognitive
impairment who were initially living in the community
would be expected to generate costs averaging £1059
over a 6-month period for care home admission.
Estimates of these expected average costs indicated a
monotonic association with higher levels of cognitive
impairment regardless of destination outcome, driven
mainly by probability of admission.
Table 4 Two-part model estimates for mental health inpatient admission
Probability of admission in 6 months Cost of admission over 6 months
N=5624 N=195
95% CI 95% CI
Regressors OR
Lower
bound
Upper
bound p Value
Exp
(b)
Lower
bound
Upper
bound p Value
MMSE 0.94 0.86 1.02 0.14 1.01 0.96 1.06 0.84
MMSE (squared) 1.00 1.00 1.00 0.77 1.00 1.00 1.00 0.35
Year (Ref: 2006 or earlier)
2007 0.86 0.55 1.36 0.52 1.08 0.83 1.40 0.56
2008 0.90 0.58 1.39 0.62 1.24 0.96 1.61 0.11
2009 0.50 0.31 0.83 <0.01 1.35 1.00 1.81 0.05
2010 or later 0.36 0.22 0.58 <0.01 1.35 1.02 1.78 0.04
Prior 12m General hospital
inpatient care (Ref: No history)
2.40 1.75 3.29 <0.01 1.12 0.94 1.33 0.22
Prior 12m Mental health inpatient
care (Ref: No history)
7.73 4.47 13.34 <0.01 1.75 1.37 2.22 <0.01
Age 0.96 0.94 0.98 <0.01 1.00 0.99 1.01 0.86
Gender (0=female; 1=male) 1.16 0.83 1.63 0.39 1.13 0.92 1.38 0.23
Ethnicity (Ref: White)
Caribbean/African 0.89 0.54 1.47 0.64 0.97 0.73 1.29 0.84
East/South Asian 1.21 0.53 2.75 0.66 1.42 1.04 1.95 0.03
Mixed/unknown 0.86 0.36 2.09 0.75 1.24 0.72 2.11 0.44
Partner (Ref: No partner) 1.63 1.11 2.39 0.01 0.81 0.66 1.01 0.06
Living alone (Ref: Not) 2.56 1.76 3.71 <0.01 1.08 0.89 1.32 0.44
Living conditions (HoNOS11)
Minor problems only 1.90 1.28 2.81 <0.01 0.87 0.71 1.08 0.22
Significant problems 2.06 1.32 3.21 <0.01 1.23 0.96 1.59 0.10
ADL (HoNOS10)
Minor problems only 1.23 0.69 2.19 0.49 1.12 0.77 1.62 0.55
Significant problems 0.97 0.56 1.67 0.91 1.15 0.79 1.70 0.46
Physical illness (HoNOS5)
Minor problems only 1.76 1.13 2.73 0.01 0.94 0.71 1.25 0.68
Significant problems 1.70 1.10 2.64 0.02 1.13 0.85 1.49 0.40
Agitated (HoNOS1)
Minor problems only 1.86 1.23 2.82 <0.01 0.70 0.54 0.91 0.01
Significant problems 3.59 2.36 5.45 <0.01 1.04 0.81 1.32 0.77
Depression (HoNOS7)
Minor problems only 0.92 0.63 1.33 0.65 1.20 0.96 1.50 0.11
Significant problems 2.04 1.35 3.09 <0.01 1.25 1.00 1.56 0.05
Relationship (HoNOS9)
Minor problems only 1.20 0.80 1.80 0.38 1.06 0.85 1.33 0.57
Significant problems 1.71 1.13 2.60 0.01 0.92 0.73 1.16 0.51
Constant term 0.42 0.07 2.67 0.36 17 397 52.66 57 476 <0.01
Reference group for all HoNOS variables: no problem. Exp(b) estimate is a ratio of expected cost, which can be interpreted as the percentage
change in estimated costs (=100×[exp(b)−1]) for each unit change in an independent variable.
HoNOS, Health of the Nation Outcome Scale; MMSE, Mini-Mental State Examination.
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For care home admission, mean expected costs for
people with severe (£1029; 95% CI £773 to £1346) or
moderate (£784, 95% CI £666 to £902) cognitive impair-
ment were at least double the costs for those with mild
impairment (£325; 95% CI £239 to £411). Bootstrapped
estimates (table 7) show that the differences between
severity levels are signiﬁcant.
For general hospital inpatient admission, mean
expected costs for people with severe cognitive impair-
ment (£1805; 95% CI £1343 to £2267) were about 1.5
times higher than those with moderate impairment
(£1204; 95% CI £1042 to £1367), and almost double the
size when compared to those with mild impairment
(£987; 95% CI £837 to £1137). Differences between
severity levels were signiﬁcant (table 7).
Turning to mental health inpatient care, mean
expected costs associated with severe cognitive impair-
ment (£1921; 95% CI £1259 to £2583) were three times
higher than those with mild impairment (£625; 95% CI
£370 to £880). However, CIs were wide for the individual
differences between severe and moderate impairment
(mean difference: £852; 95% CI £133 to £1570) and
between moderate and mild impairment (mean differ-
ence: £443; 95% CI £39 to £848).
Table 5 Two-part model estimates for any institutional admission
Probability of admission in 6 mths Cost of admission over 6 mths
N=5624 N=1392
95% CI 95% CI
Regressors OR
Lower
bound
Upper
bound p Value Exp (b)
Lower
bound
Upper
bound p Value
MMSE 0.93 0.89 0.97 <0.01 1.01 0.97 1.05 0.56
MMSE (squared) 1.00 1.00 1.00 0.17 1.00 1.00 1.00 0.08
Year (Ref: 2006 or earlier)
2007 1.08 0.87 1.34 0.49 0.99 0.80 1.21 0.89
2008 1.22 0.99 1.51 0.06 0.97 0.80 1.19 0.76
2009 1.12 0.90 1.38 0.31 0.87 0.71 1.06 0.17
2010 or later 1.03 0.85 1.27 0.74 0.86 0.71 1.05 0.13
Prior 12m General hospital
inpatient care (Ref: No history)
2.14 1.87 2.45 <0.01 1.19 1.06 1.35 <0.01
Prior 12m Mental health inpatient
care (Ref: No history)
2.15 1.35 3.41 <0.01 2.89 2.30 3.64 <0.01
Age 1.03 1.02 1.04 <0.01 1.00 0.99 1.01 0.52
Gender (0=female; 1=male) 1.31 1.12 1.53 <0.01 0.99 0.86 1.14 0.90
Ethnicity (Ref: White)
Caribbean/African 0.65 0.51 0.82 <0.01 0.76 0.61 0.95 0.02
East/South Asian 0.56 0.36 0.90 0.01 1.35 0.88 2.07 0.17
Mixed/Unknown 1.07 0.74 1.55 0.71 0.78 0.57 1.08 0.14
Partner (Ref: No partner) 0.79 0.67 0.93 <0.01 0.86 0.74 1.01 0.06
Living alone (Ref: Not) 1.34 1.13 1.58 <0.01 1.20 1.05 1.37 0.01
Living conditions (HoNOS11)
Minor problems only 1.43 1.19 1.73 <0.01 1.27 1.08 1.49 <0.01
Significant problems 1.89 1.50 2.38 <0.01 1.34 1.13 1.60 <0.01
ADL (HoNOS10)
Minor problems only 1.16 0.93 1.45 0.18 1.09 0.85 1.41 0.49
Significant problems 1.29 1.05 1.60 0.02 1.10 0.87 1.38 0.42
Physical illness (HoNOS5)
Minor problems only 1.30 1.09 1.56 <0.01 1.08 0.90 1.29 0.41
Significant problems 2.05 1.56 2.44 <0.01 1.09 0.91 1.29 0.36
Agitated (HoNOS1)
Minor problems only 1.26 1.06 1.51 0.01 1.13 0.97 1.30 0.11
Significant problems 1.97 1.59 2.42 <0.01 1.54 1.32 1.81 <0.01
Depression (HoNOS7)
Minor problems only 0.91 0.77 1.07 0.24 1.07 0.92 1.24 0.37
Significant problems 1.52 1.22 1.90 <0.01 1.31 1.09 1.58 <0.01
Relationship (HoNOS9)
Minor problems only 1.07 0.89 1.27 0.47 1.09 0.94 1.28 0.25
Significant problems 1.10 0.88 1.37 0.40 1.13 0.95 1.33 0.16
Constant term 0.02 0.01 0.06 <0.01 9704.3 4157.3 22 653 <0.01
Reference group for all HoNOS variables: no problem. Exp(b) estimate is a ratio of expected cost, which can be interpreted as the percentage
change in estimated costs (=100×[exp(b)−1]) for each unit change in an independent variable.
HoNOS, Health of the Nation Outcome Scale; MMSE, Mini-Mental State Examination.
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Combining all destinations into one dependent vari-
able, our estimates show that mean expected costs asso-
ciated with severe cognitive impairment (£4948; 95% CI
£3762 to £6135) were much higher than those with
moderate impairment (£3163; 95% CI £2728 to £3598)
or mild impairment (£2008; 95% CI £1704 to £2311).
Bootstrapped estimates (table 7) suggested that differ-
ences between different levels of cognitive impairment
were robust.
Sensitivity analysis
Using GLM rather than GEE to estimate the equations
did not greatly change the results (see online
supplementary appendix tables 1 –4).
Excluding the ADL and depression variables from the
regressions made very little difference to the coefﬁcient
values or signiﬁcance for the MMSE variables (see
online supplementary appendix tables 5 –8).
To test whether our ﬁndings for the marginal estimates
were sensitive to the MMSE scores chosen for our three
‘case values’, we repeated our analyses with a different set
of values (MMSE scores of 9, 16 and 22 for mild, moder-
ate, and severe impairment, respectively). These results
led us to the same conclusions regarding cost differences
(see online supplementary appendix tables 9 and 10).
We estimated MEMs and compared with our AME esti-
mates. MEM estimates were generally smaller than the
AME estimates, but the same substantive conclusions
Table 6 Average costs estimates (average marginal effects (AME))
Bootstrapped 95% CI
AME
probability AME cost
Bootstrapped
estimated cost Lower bound Upper bound
Care home
MMSE 6 (severe) 0.10 10,172.23 1059.23 772.89 1345.58
MMSE 16 (moderate) 0.08 9782.47 784.00 665.58 902.42
MMSE 24 (mild) 0.03 9424.14 325.37 239.24 411.49
General hospital inpatient care
MMSE 6 (severe) 0.29 6313.06 1805.13 1343.35 2266.90
MMSE 16 (moderate) 0.21 5754.21 1204.37 1041.94 1366.80
MMSE 24 (mild) 0.18 5355.17 987.04 836.97 1137.12
Mental health inpatient care
MMSE 6 (severe) 0.06 32,874.80 1920.58 1258.59 2582.57
MMSE 16 (moderate) 0.04 29,441.30 1068.82 730.66 1406.99
MMSE 24 (mild) 0.03 24,248.87 624.89 370.08 879.71
Any institutional care
MMSE 6 (severe) 0.37 13,543.53 4948.17 3761.50 6134.84
MMSE 16 (moderate) 0.26 11,946.93 3163.18 2728.28 3598.08
MMSE 24 (mild) 0.22 9230.684 2007.63 1703.81 2311.45
MMSE, Mini-Mental State Examination.
Table 7 Estimated difference between AMEs
Bootstrapped estimated
cost difference
Bootstrapped 95%
CI (lower bound)
Bootstrapped 95%
CI (upper bound) p Value
Care home
MMSE severe versus mild 733.87 424.89 1042.85 <0.001
MMSE severe versus moderate 275.24 −16.49 566.96 0.064
MMSE moderate versus mild 458.63 317.90 599.37 <0.001
General hospital inpatient care
MMSE severe versus mild 818.09 315.34 1320.83 0.001
MMSE severe versus moderate 600.76 147.04 1054.48 0.009
MMSE moderate versus mild 217.33 7.74 426.92 0.042
Mental health inpatient care
MMSE severe versus mild 1295.68 506.93 2084.43 0.001
MMSE severe versus moderate 851.76 133.10 1570.42 0.020
MMSE moderate versus mild 443.93 39.93 847.93 0.031
Any care
MMSE severe versus mild 2940.54 1738.96 4142.12 0.001
MMSE severe versus moderate 1784.99 653.34 2916.63 0.002
MMSE moderate versus mild 1155.55 669.32 1641.79 0.001
AMEs, marginal costs estimates; MMSE, Mini-Mental State Examination.
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were reached with either approach (see online
supplementary appendix tables 11 and 12).
DISCUSSION
Summary
A theme running through Government policy in
England—in the National Dementia Strategy 2009,28
and in the two Prime Minister’s Challenge issued in
201229 and 201530—has been to emphasise the desirabil-
ity of people with dementia being able to remain in
their own homes for as long as possible. The high per
diem costs of institutional settings, combined with a
common and understandable reluctance among people
with dementia to move from their own homes, make it
important that strategic decision-makers and commis-
sioners understand the circumstances under which indi-
viduals are at risk of such admissions.
We explored the links between, on the one hand, cog-
nitive function and other characteristics of people with
Alzheimer’s disease living in community settings and, on
the other hand, the probability of admission to care
home or inpatient settings, and the associated costs. We
used observational data from a large mental health pro-
vider in London. The observation period for each study
participant was broken into 6-month windows so that
assessment data over multiple time-points could better
reﬂect the level of cognitive impairment closer to the
time when costs were incurred. The estimation of
average costs took into account concomitant inﬂuences
of physical and mental health, sociodemographic factors
and living circumstances.
We found that a range of patient characteristics and
living circumstances were independent predictors of the
probability of admission to either care home, general
inpatient or mental health inpatient settings, and/or the
associated costs over the 6-month period. Important pre-
dictors included cognition, functional or ADL-related
problems, agitation, depression, physical illness, previous
hospitalisations, age, gender, ethnicity, living alone, and
having a partner. However, patterns of association dif-
fered by the type of destination, as discussed below.
Strengths and limitations
A strength of the study was that our large sample was
inclusive of all patients diagnosed with Alzheimer’s
disease on the electronic medical record system of a
large mental healthcare service provider that is a near-
monopoly provider for its geographical catchment. In
the UK, such mental healthcare NHS Trusts are the pre-
dominant providers of dementia assessment and specia-
lised healthcare for people with dementia. Our study is
unusual in using natural language processing to gener-
ate some of the data from clinical records, demonstrat-
ing the potential to use real-world data to explore
patterns of association in standard services. We looked at
three institutional destinations separately: care home,
general hospital inpatient and mental health inpatient.
This is important because they not only have different
per diem costs which fall to different budgets, but also are
associated in different ways with patient-level predictors
of admission (and cost).
Our analyses controlled for a wide range of patient
characteristics as potential confounders, but we were
constrained by what was available in the records-derived
data set. There may have been residual confounding
from covariates not included, such as pharmacological
or other treatments, lifestyle choices (eg, alcohol intake,
smoking, diet or physical activity) and illness duration.
Certain measures, such as those based on HoNOS items,
are widely used in routine clinical care but lack measure-
ment precision, and we would caution against overinter-
pretation; this is a familiar limitation of using
‘real-world’ data. We could not explore any supply-side
inﬂuences such as availability of care home places in the
catchment, nor did we have data on carer burden,
which has been found to be a predictor of nursing
home admission.4–6 31 We did not look at pharmaco-
logical, psychological or other interventions as potential
predictors. We did not have an indicator of duration of
illness prior to MMSE assessment.
We did not have data on usage of primary or commu-
nity health or social care services, but we did not set out
to study the comprehensive costs of supporting people with
Alzheimer’s disease. Unit costs employed to weight dura-
tions of stay are available as national averages for each
type of setting, and do not reﬂect any within-setting dif-
ferences linked to individual needs or characteristics;
this is common to all such work in this area. Costs for
care homes are averages across residents with and
without dementia, although most UK care homes today
have high proportions of residents with dementia.32 We
did not have data on the actual length of stay in care
home as the administrative data sets recorded only the
ﬁrst instance of care home admission, although very few
residents leave a home permanently after admission.33
Implications for policy and practice
All secondary mental healthcare within the four bor-
oughs that form the SLAM catchment is provided free at
the point of use to patients as part of the NHS, but the
characteristics of those known to secondary care may
still be inﬂuenced by levels of disadvantage or referral
bias. Consequently, the generalisability of these ﬁndings
is principally to secondary care rather than primary care
populations.
Patterns of prediction were quite different for the
three destination outcomes studied, and the implications
for policy and practice therefore require individual
consideration.
Looking ﬁrst at care homes, the probability of admission
was higher for Alzheimer’s disease patients with greater
severity of cognitive impairment, more severe functional
problems and greater agitation. Other predictors of
higher probability were general hospital or mental
health hospitalisation in the previous 12 months, who
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were older, not of Caribbean/African or other Black or
unknown ethnicity, who did not have a partner, who
lived alone and who had received ratings for poor living
conditions. Factors not associated with care home admis-
sion were physical illness, depression, gender, relation-
ship problems or year in which assessment was carried
out. The only signiﬁcant predictor of care home-related
costs was ‘living alone’, associated with lower costs. Other
studies of care/nursing home admissions—for older
people in general, or for people with dementia in par-
ticular—have found that cognition, ADLs, behavioural
problems (including agitation), living alone, older age,
poor overall health and prior nursing home use are
important predictors.4 6 31 34 35
For general hospital inpatient stays, admission probability
was higher for patients with more severe cognitive
impairment, physical illness, agitation, depression, with a
previous general hospital stay in the past 12 months,
who were older, female, of White ethnicity, without a
partner, living alone and with poor living conditions.
Factors not associated with general hospital admission
were ADL and relationship problems. Costs associated
with general hospital inpatient stays during the 6-month
window were higher for individuals with physical health
problems, a previous hospitalisation in the year before
assessment, older age, and not of Caribbean, African or
other Black ethnicity.
The probability of mental health inpatient admission was
higher for patients with physical illness, agitation,
depression, with a previous inpatient hospital stay in the
past 12 months, who were younger, with a partner, living
alone, with poor living conditions, relationship problems
and assessed later in the research period. Factors not
associated with mental health inpatient admission were
cognition, ADL problems, gender and ethnicity. Mental
health inpatient costs during the 6-month window were
higher for individuals with agitation, depression, of
East/South Asian ethnicity, with a previous mental
health-related hospital stay in the year before assessment
and who were assessed later in the research period.
Therefore, while admission to mental health inpatient
treatment became less common over time (other things
being equal), its cost was greater in later years for those
people who were admitted. A recent systematic review
and meta-analysis found that behavioural problems
(including agitation and wandering) and ADLs were
associated with higher risk of hospitalisation for people
with dementia.36
Cognitive impairment is a signiﬁcant predictor of care
home and general hospital admissions, and of the
overall risk of institutionalisation, but—as discussed
below—other individual characteristics are also import-
ant. Some cost differences are revealed when we look at
our selected MMSE ‘case values’. For example, care
home costs for people with moderate to severe cognitive
impairment are double than those for people with mild
impairment, although the cost difference was much
smaller between moderate and severe impairment.
General hospital inpatient costs for people with severe
cognitive impairment were approximately double than
those for people with less moderate or mild severity (but
there was no cost difference between our moderate and
mild ‘case values’). In our analyses, the observed costs
differences are inﬂuenced more by probability of admis-
sion than duration of stay, although we are looking at
only 6-month periods. Interventions in the community
that can slow down the rate of cognitive decline, at least
for a short while, such as some medications7 37 and cog-
nitive stimulation therapy,38 could help to delay care
home and hospital admissions; most people with demen-
tia want to stay in their own homes. This is generally also
seen as a lower-cost option than admission,5 but this will
not always be the case.39 Recognising and ﬁnding ways
to reduce or manage physical health problems,36 agita-
tion40 and depression41 in Alzheimer’s patients could
signiﬁcantly reduce the risk of institutionalisation, which
has implications for primary and secondary healthcare.
Problems with ADL are also important predictors of
care home admission and overall institutionalisation risk.
Deterioration in ADLs could be linked to disease pro-
gression itself, but ameliorative action by community-
based social care services could also potentially help to
postpone care home admission.42 Poor living conditions
are also a risk factor for institutionalisation, a problem
that might be seen as a responsibility of public sector
social care or housing services, or that might be
addressed by local voluntary agencies. Although almost
clichéd, these ﬁndings emphasise the need for effective
integrated working between a range of health, social
care and other services.
Supporting unpaid carers is another strategy with the
potential to delay admissions. Although in our data set we
do not have measures of carer burden or mental health,
we ﬁnd that Alzheimer’s patients living alone have much
higher probabilities of admission to all settings, after
adjusting for all other covariates, indicating how coresi-
dence with someone else (who may or may not be a
carer) is a protective factor against institutional admission.
Implications for future research
A number of recommendations can be drawn for future
research, but we will concentrate here on the most
important. One of our ﬁndings is that destination
matters: the transition of someone with dementia from
their own home in the community to a care home or
inpatient setting is inﬂuenced by different individual
characteristics—especially their health and functioning—
and various living circumstances. Researcher should there-
fore avoid aggregating different care destinations when
looking at, for example, the risk of institutionalisation.
There is also a need to look not just at cognition but
at a range of other symptoms (such as agitation, depres-
sion and physical health) and needs (such as independ-
ence in ADL) in order to get a fuller understanding of
what factors inﬂuence pathways and costs of care for
Alzheimer’s disease patients.
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Our study shows that it is now possible to model
service patterns and care pathways from real-world data
derived from context-appropriate systems in the UK.
This would make it possible in future to examine the
potential impact on costs of modifying the cognitive tra-
jectory of dementia—or indeed other symptoms—with
either disease-modifying or symptomatic therapies.
Using real-world data in such models might have consid-
erable beneﬁts compared to other approaches using
modelling from data derived from clinical trials which
are typically short in length and where the trials partici-
pants may not be entirely typical of the population in
the community.
The use of real-world data using a combination of
pseudonymised extracts of coded and non-coded data
and the derivation of information from the non-coded
or narrative data in clinical records using natural lan-
guage processing raises the prospect of very signiﬁcantly
increasing not only the ecological validity but also the
scale of data sets used in analyses of care pathways,
service use patterns, costs and outcomes.
This study employed data derived from an information
system of a large, mental healthcare provider in the UK.
As electronic medical records become increasingly uni-
versal, as indeed they already are in mental healthcare
in the UK, then it will become possible to derive data
from multiple providers, allowing not only studies at scale
but also the prospect of comparison across providers
and geographical areas. This has international rele-
vance, of course, even though the structural character-
istics, funding arrangements and associated incentives in
different health and care systems often lead to different
patterns of service usage and costs.39
CONCLUSION
Most people with dementia would like to remain in their
own homes for as long as possible, rather than move
into a care home or inpatient setting. This is usually the
preference of family members too, although the respon-
sibilities of being a carer can become very burdensome
as dementia becomes more severe, particularly for
spouse carers who will often also have to cope with their
own healthcare needs. Community-based care is also
seen as a lower-cost option than care home residence
(and much cheaper than a protracted inpatient stay),
and is therefore encouraged by governments or other
health and social care funders concerned about the
current and future affordability of dementia care.
With the help of data from the clinical records of a
large mental health provider—extracted using novel
techniques to generate rich information on each of
more than 3000 patients with Alzheimer’s disease—we
showed that the risks of admission to a care home,
general hospital or mental health inpatient care are
driven by a number of patient characteristics and living
circumstances. We were also able to examine the patient
and other factors associated with care home and
inpatient costs. A number of factors were found to be
signiﬁcant, although different combinations of factors
inﬂuenced the different destinational outcomes.
Patient health measures of relevance were cognition,
agitation, depression and physical illness, and abilities in
ADLs were important in understanding care home
admissions. Treatment or care that can reduce these
health and social care needs could potentially reduce
rates of admission. The effect of older age on admission
varied according to destination, having a positive effect
on care home and general hospital admission, but a
negative effect on mental health inpatient care. The
effect of having a partner was also different: it reduced
the likelihood of care home and general hospital admis-
sion, but increased the likelihood of mental health
inpatient care. Living alone was a risk factor for all types
of admission, and as the UK population ages the
number of people living alone demography of the UK
changes, with more people living into old age and a
high proportion living alone, so the demand for institu-
tional placements could increase.
Those patients who had been admitted as an inpatient
in the previous 12 months had a higher probability of
subsequent admission to all three of the destinations we
studied here. Whether anything can be carried out at
hospital discharge to reduce future risks is beyond the
scope of this paper. We also found differences in admis-
sion patterns between ethnic groups.
Poor living conditions were also shown to be a risk
factor for all three destinational outcomes, but major cut-
backs in public expenditure on social care in England in
recent years have made it increasingly difﬁcult for local
authorities to provide preventative services in the commu-
nity. These cutbacks could in time put further pressure
on high-cost residential and inpatient services.
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